-
J&J adds $1B to opioid settlement
Johnson & Johnson said Oct. 13 that it is adding $1 billion to the opioid settlement agreement it made with four states last year, bringing its total contribution to $5 billion. -
Ohio judges postpone 2 major trials blaming pharmacies, distributors for opioid epidemic
Judges in Ohio have postponed two major opioid trials involving lawsuits that seek to penalize drugmakers and distributors for the opioid epidemic that has killed thousands of Ohioans during the last 20 years, according to Cleveland.com. -
West Virginia pharmacist receives 10-year prison sentence for opioid trafficking scheme
Jackson Noel, PharmD, was sentenced to 10 years in prison Sept. 30 for an illegal opioid distribution scheme, according to the U.S. Attorney's Office in the Eastern District of Kentucky. -
Senator raises concerns about Purdue Pharma's bankruptcy court location
Sen. Tammy Baldwin, D-Wis., wrote a letter to Purdue Pharma's board members Sept. 29 requesting they release emails and any other information related to the drugmaker's choice to change its New York address for receiving legal documents from Albany to White Plains. -
FDA opioid approvals relied on short trials, patient exclusions, study contends
None of the clinical trials for opioids the FDA approved to treat chronic pain from 1997 to 2018 lasted longer than three months, according to research published Sept. 29 in Annals of Internal Medicine. -
Senators urge bankruptcy judge to block Purdue Pharma CEO's $3.5 million bonus
Four U.S. senators wrote a letter to U.S. Bankruptcy Judge Robert Drain Sept. 21, in which they urged him to prevent Purdue Pharma from paying its CEO a $3.5 million bonus. -
New York hits J&J with lawsuit over opioid marketing
New York 's department of financial services sued Johnson & Johnson Sept. 17, accusing the drugmaker of misrepresenting opioids in its marketing. -
Taxing drugmakers, distributors for opioid treatment programs upheld by US appeals court
The U.S. Appeals Court for the Southern District of New York on Sept. 14 upheld a New York law taxing drugmakers and distributors to help address the opioid epidemic. -
HHS gives communities $115M to fight the opioid epidemic in 2020
The Health Resources and Services Administration, part of HHS, on Sept. 14 awarded $25 million to 80 organizations across 36 states and two territories to combat the opioid crisis. -
Large US counties show uptick in overdose deaths
Opioid overdose deaths are trending up compared to 2019 in at least 21 of the largest counties in the U.S., new data collected by The Wall Street Journal shows. -
Medicaid spending on naloxone increased 13,500% in recent years, study finds
Medicaid spending on opioid overdose-reversal drug naloxone shot up from $110,000 in 2010 to close to $15 million in 2018, according to a study released Aug. 26 by Washington, D.C. think tank the Urban Institute.
Page 9 of 50